Clinical trial designs for testing biomarker-based personalized therapies. - Wikidata - wikimedia - TriplyDB

Clinical trial designs for testing biomarker-based personalized therapies.

Clinical trial designs for testing biomarker-based personalized therapies.

http://www.wikidata.org/entity/Q34977663

about

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity Multicenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.Evaluating many treatments and biomarkers in oncology: a new design Commentary on Hey and Kimmelman Clinical trial designs incorporating predictive biomarkers.Adaptive Clinical Trials: Overview of Early-Phase Designs and Challenges.Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.

P2860

Q26766584-2CD99CF9-6D1E-4A7D-BDD6-896027C04DDB Q26992272-0ABE33F7-6397-4F75-8E61-4CBD72971A5D Q33921056-8E12AEE1-18E6-4215-AEE9-9FBB6C9FA560 Q35379179-10EF822E-23AA-480F-B513-31BA7AE87ECC Q35820701-C1953F20-9FFC-4C8C-9845-14EEAE3CA3FD Q36534713-31BF65E6-62C5-4400-BEBF-6E27A1BF93D2 Q38697445-998A4685-D9D0-43B0-B6C6-8B05EE0B0D29 Q47694209-BE1915C3-F49A-485C-A021-BF6D3413B72E

P2860

Clinical trial designs for testing biomarker-based personalized therapies.

http://www.wikidata.org/entity/Q34977663

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Clinical trial designs for testing biomarker-based personalized therapies.

@ast

Clinical trial designs for testing biomarker-based personalized therapies.

@en

Clinical trial designs for testing biomarker-based personalized therapies.

@nl

type

label

Clinical trial designs for testing biomarker-based personalized therapies.

@ast

Clinical trial designs for testing biomarker-based personalized therapies.

@en

Clinical trial designs for testing biomarker-based personalized therapies.

@nl

prefLabel

Clinical trial designs for testing biomarker-based personalized therapies.

@ast

Clinical trial designs for testing biomarker-based personalized therapies.

@en

Clinical trial designs for testing biomarker-based personalized therapies.

@nl

P1433

Q34977663-9D41DF9F-A5BA-4D3F-92CB-1C53FC2B91FF

P1476

Q34977663-7E440B19-AC09-4922-93C2-B56496BDF557

P2093

Q34977663-00CFF37A-7E8A-418B-89C8-7FF4437181A0

Q34977663-77C934F0-F6D5-4D86-96DB-8744D25F5A57

Q34977663-BE2DEA2A-3802-4F0F-9FEC-3B60C2466617

Q34977663-F235B6AB-1C16-449E-A1AA-E905728F7C12

P2860

Q34977663-0108CA1F-A3E7-4A7C-83CE-F345B9732094

Q34977663-0116EBF1-E327-4895-B88E-45BEACF562C1

Q34977663-077D2C3C-BC89-428A-93B2-4BC2C06E686A

Q34977663-154FD85C-6006-4CF0-96EF-DA39562B9010

Q34977663-192B656D-0AFE-40D9-B254-5B23FF908766

Q34977663-27686CD5-A873-44F5-8F67-94AADA24E410

Q34977663-2BB709F9-7B2C-4FD6-829C-1AEF9EBEEB7F

Q34977663-2C07B1EA-5BF0-4366-B382-DFD77ECC12B1

Q34977663-30874743-97DA-4CC8-9548-A8B88C3887E0

Q34977663-370CE891-A80A-4EA3-9E2C-1608D145A303

P304

Q34977663-09881106-CD41-40E7-9CF3-5BEE75729B40

P31

Q34977663-757BB5E1-1577-46A6-AC7A-FEFB596E65D5

P356

Q34977663-50443BFD-453E-4E1C-B57F-3B33FB1727CC

P433

Q34977663-7B7048D0-B128-45B1-9C49-C792698EAFC0

P478

Q34977663-AA77CB50-9982-4CA4-9D93-D6555F7AD4D2

P577

Q34977663-BF9A506E-38E2-4194-9A83-2F84DEE57753

P5875

Q34977663-795FCCE1-572C-4647-9FB4-064AF35D1ADE

P698

Q34977663-4D1AAF00-51A0-4C8D-B78D-FA568846C7C1

P921

Q34977663-FFD0A3D0-E9D6-4E30-849C-7A21BFB5A533

P932

Q34977663-40D1880E-1309-48D8-A2CF-3BFA5641783A

P356

1740774512437252

P1433

Clinical Trials

P1476

Clinical trial designs for testing biomarker-based personalized therapies.

@en

P2093

Branimir I Sikic

http://www.w3.org/2001/XMLSchema#string

Mei-Chiung I Shih

http://www.w3.org/2001/XMLSchema#string

Philip W Lavori

http://www.w3.org/2001/XMLSchema#string

Tze Leung Lai

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression patterns in ovarian carcinomas

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy

Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.

A simulation study for comparing testing statistics in response-adaptive randomization.

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology.

Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine.

Randomized clinical trials with biomarkers: design issues.

Predictive biomarker validation in practice: lessons from real trials.

The BATTLE trial: personalizing therapy for lung cancer.

P304

141-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1740774512437252

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221684448

http://www.w3.org/2001/XMLSchema#string

P698

22397801

http://www.w3.org/2001/XMLSchema#string

P921

P932

4296980

http://www.w3.org/2001/XMLSchema#string